Skip to Main Content

Paper Details

Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia.
Oncogene
9
2015
A572V, FERM, IL2R, IL2R interaction site, JAK, JAK1, JAK3, JAK3 mutant, JAK3 mutations, JAK3(A572V), JAK3(A572V) mutation-positive acute myeloid, JAK3(M511I), JAK3-, JAK3-mutation, JAK3-mutation-positive leukemia, M511I, MAPK, STAT, STAT5, Y100C, acute myeloid, for a, interleukin-2 gamma receptor, leukemia, leukemia cell line, leukemic, leukemic cell, murine cells, pS6 ribosomal protein, primary, primary leukemia, wild-type JAK3
Author NameAffiliation
Anupriya AgarwalOregon Health & Science University, USA [2] Knight Cancer Institute
Ryan J MackenzieOregon Health & Science University, USA [2] Knight Cancer Institute
Christopher A EideOregon Health & Science University, USA [2] Knight Cancer Institute, USA [3] Howard Hughes Medical Institute
Monika A DavareOregon Health & Science University
Monika A DavareOregon Health & Science University
Kevin Watanabe-SmithOregon Health & Science University, USA [2] Knight Cancer Institute
Cristina E Tognon1] Knight Cancer Institute, Oregon Health & Science University, USA [2] Howard Hughes Medical Institute
Solange Mongoue-Tchokote1] Knight Cancer Institute, Oregon Health & Science University
Byung Park1] Knight Cancer Institute, Oregon Health & Science University
Jeffrey W Tyner1] Knight Cancer Institute, Oregon Health & Science University
Brian J DrukerOregon Health & Science University, USA [2] Knight Cancer Institute, USA [3] Howard Hughes Medical Institute
  • 1 - 11

Datasets

Release 1.2